Evidence map›Paper›PMID 29073114›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2017

Pathogenesis of hypothyroidism-induced NAFLD is driven by intra- and extrahepatic mechanisms.

Giuseppe Ferrandino, Rachel R Kaspari, Olga Spadaro, Andrea Reyna-Neyra, Rachel J Perry, Rebecca Cardone, Richard G Kibbey, Gerald I Shulman, Vishwa Deep Dixit, Nancy Carrasco

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed, 1 pooled it
4.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 1 synthesis or guideline pooled it, 75 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Thyroid dysfunction in MASLD: Results of a nationwide study.JHEP reports : innovation in hepatology · 2025
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Giuseppe FerrandinoDepartment of Cellular and Molecular Physiology, Yale School of Medicine, New Haven, CT 06510.
Rachel R KaspariDepartment of Cellular and Molecular Physiology, Yale School of Medicine, New Haven, CT 06510.
Olga SpadaroDepartment of Comparative Medicine, Yale School of Medicine, New Haven, CT 06510.
Andrea Reyna-NeyraDepartment of Cellular and Molecular Physiology, Yale School of Medicine, New Haven, CT 06510.
Rachel J PerryDepartment of Internal Medicine, Yale School of Medicine, New Haven, CT 06510.
Rebecca CardoneDepartment of Internal Medicine, Yale School of Medicine, New Haven, CT 06510.
Richard G KibbeyDepartment of Cellular and Molecular Physiology, Yale School of Medicine, New Haven, CT 06510.
Gerald I ShulmanDepartment of Cellular and Molecular Physiology, Yale School of Medicine, New Haven, CT 06510.
Vishwa Deep DixitDepartment of Comparative Medicine, Yale School of Medicine, New Haven, CT 06510.
Nancy CarrascoDepartment of Cellular and Molecular Physiology, Yale School of Medicine, New Haven, CT 06510; nancy.carrasco@yale.edu.
Yale University · USHoward Hughes Medical Institute · US

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
Yale Diabetes Research CenterP30DK045735 · NIDDK · YALE UNIVERSITY · PI Kevan C Herold, GERALD I SHULMAN · 1993 to 2026
$44.0M
The role of AgRP/Auga-ALK pathway in FGF21's brain action on agingP01AG051459 · NIA · YALE UNIVERSITY · PI VISHWA DEEP DIXIT · 2016 to 2026
$25.7M
Yale Mouse Metabolic Phenotyping CenterU24DK059635 · NIDDK · YALE UNIVERSITY · PI SHULMAN, GERALD I · 2001 to 2015
$8.9M
THYROID SODIUM I/ SYMPORTERR01DK041544 · NIDDK · YESHIVA UNIVERSITY · PI ABBOTT, GEOFFREY W, CARRASCO, NANCY · 1989 to 2017
$5.6M
Mechanisms of Lipid-Induced Hepatic Insulin ResistanceR01DK040936 · NIDDK · YALE UNIVERSITY · PI SHULMAN, GERALD I · 1989 to 2015
$5.1M
Comprehensive, Cross Platform-Validated 13C Flux Measures of Intra-and Inter-tissue MetabolismR01DK108283 · NIDDK · YALE UNIVERSITY · PI KIBBEY, RICHARD G, MASON, GRAEME F. · 2016 to 2019
$2.1M
Thymic adipogenesis and age-related thymic demiseR01AI105097 · NIAID · YALE UNIVERSITY · PI DIXIT, VISHWA DEEP · 2015 to 2018
$1.9M
Impact of Ketone Metabolites on Inflammasome Deactivation in GoutR01AR070811 · NIAMS · YALE UNIVERSITY · PI DIXIT, VISHWA DEEP · 2017 to 2021
$1.8M
Inflammasomes and the mechanism of thymic demise in agingR01AG043608 · NIA · YALE UNIVERSITY · PI DIXIT, VISHWA DEEP · 2013 to 2017
$1.8M
Chastening the double-edged sword of glucose metabolism in beta-cellsR01DK110181 · NIDDK · YALE UNIVERSITY · PI KIBBEY, RICHARD G · 2016 to 2019
$1.7M
Thymic adipogenesis and age-related thymic demiseR56AI105097 · NIAID · YALE UNIVERSITY · PI DIXIT, VISHWA DEEP · 2013 to 2013
$348k
Howard Hughes Medical InstituteNCATS NIH HHS UL1 TR001863NIAID NIH HHS R01 AI105097NIAID NIH HHS R56 AI105097NIAMS NIH HHS R01 AR070811NIA NIH HHS P01 AG051459NIA NIH HHS R01 AG043608NIDDK NIH HHS P30 DK045735NIDDK NIH HHS R01 DK040936NIDDK NIH HHS R01 DK041544NIDDK NIH HHS R01 DK108283NIDDK NIH HHS R01 DK110181NIDDK NIH HHS U24 DK059635
6 · The paper itself

Abstract

Hypothyroidism, a metabolic disease characterized by low thyroid hormone (TH) and high thyroid-stimulating hormone (TSH) levels in the serum, is strongly associated with nonalcoholic fatty liver disease (NAFLD). Hypothyroidism-induced NAFLD has generally been attributed to reduced TH signaling in the liver with a consequent decrease in lipid utilization. Here, we found that mildly hypothyroid mice develop NAFLD without down-regulation of hepatic TH signaling or decreased hepatic lipid utilization. NAFLD was induced by impaired suppression of adipose tissue lipolysis due to decreased insulin secretion and to a reduced response of adipose tissue itself to insulin. This condition leads to increased shuttling of fatty acids (FAs) to the liver, where they are esterified and accumulated as triglycerides. Lipid accumulation in the liver induces hepatic insulin resistance, which leads to impaired suppression of endogenous glucose production after feeding. Hepatic insulin resistance, synergistically with lowered insulin secretion, increases serum glucose levels, which stimulates de novo lipogenesis (DNL) in the liver. Up-regulation of DNL also contributes to NAFLD. In contrast, severely hypothyroid mice show down-regulation of TH signaling in their livers and profound suppression of adipose tissue lipolysis, which decreases delivery of FAs to the liver. The resulting lack of substrates for triglyceride esterification protects severely hypothyroid mice against NAFLD. Our findings demonstrate that NAFLD occurs when TH levels are mildly reduced, but, paradoxically, not when they are severely reduced. Our results show that the pathogenesis of hypothyroidism-induced NAFLD is both intra- and extrahepatic; they also reveal key metabolic differences between mild and severe hypothyroidism.

Indexed as

Insulin ResistanceAdipose TissueAnimalsDisease Models, AnimalHypothyroidismInsulinInsulin-Secreting CellsInsulin SecretionLipid MetabolismLipolysisLiverMaleMice, Inbred C57BLMice, KnockoutNon-alcoholic Fatty Liver DiseaseObesityInsulinSodium-Iodide SymportersSymportersde novo lipogenesishypothyroidisminsulin resistanceNAFLDsodium/iodide symporter

Identifiers

PMID29073114
PMCPMC5664516
OpenAlexW2763408555

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.